You just read:

Impax Pharmaceuticals Announce FDA Approval of RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules for the Treatment of Parkinson's disease

News provided by

Impax Laboratories, Inc.

Jan 08, 2015, 08:01 ET